Who is sponsoring NCT05463978?

NCT05463978 is sponsored by Galderma R&D.

What drugs are being tested in NCT05463978?

Interventions in NCT05463978: Sculptra Aesthetic.

What condition does NCT05463978 study?

NCT05463978 studies Non-facial Skin Aesthetic Conditions.

Is NCT05463978 still recruiting?

NCT05463978 is currently completed. Last updated 24 October 2022.

Last reviewed 2022-10-24 · How we verify

NCT05463978

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sculptra Chart Review

Completed Last updated 24 October 2022

What this trial tests

trial testing Sculptra Aesthetic in Non-facial Skin Aesthetic Conditions in 500 participants. Completed in 14 October 2022.

Timeline

14 July 2022

Primary endpoint
14 October 2022

14 October 2022

Quick facts

Lead sponsor	Galderma R&D
Status	Completed
Study type	OBSERVATIONAL
Enrollment	500
Start date	14 July 2022
Primary completion	14 October 2022
Estimated completion	14 October 2022
Sites	8 locations across United States

Drugs / interventions tested

Sculptra Aesthetic — full drug profile →

Conditions studied

Non-facial Skin Aesthetic Conditions — all drugs for Non-facial Skin Aesthetic Conditions →

Sponsor

Galderma R&D — full company profile →

Who can join

Eligibility, any sex, with Non-facial Skin Aesthetic Conditions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multi-center retrospective chart review to evaluate the safety of Sculptra Aesthetic when used in non-facial areas

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Injectable Poly-L-Lactic Acid for Body Aesthetic Treatments: An International Consensus on Evidence Assessment and Practical Recommendations.
Haddad A, Avelar L, Fabi SG, Sarubi J, et al · · 2025 · cited 4× · PMID 39592491 · DOI 10.1007/s00266-024-04499-9
Nonfacial Use of Injectable Poly-L-lactic Acid: Safety Data From a Multicenter Observational Study in the United States.
Durairaj KK, Vafa A, Aguilera SB, Fabi SG, et al · · 2026 · PMID 42004285 · DOI 10.1093/asjof/ojag053

Verify or expand the search:

Other trials of Sculptra Aesthetic

Trials testing the same drug.

NCT07202117 — PLLA and CaHA-R for Aesthetic Rejuvenation · Phase 4 · recruiting
NCT07217743 — Assess Impact of Poly-L-lactic Acid on GLP1 Subjects · Phase 2 · not yet recruiting
NCT07205744 — Post-Menopause Skin Rejuvenation Study · Phase 4 · active not recruiting
NCT04957446 — Histology Study of Biostimulatory Activity of Injectable Poly-L-Lactic Acid (Sculptra Aesthetic) · NA · unknown
NCT04830722 — Clinical Trial of Poly-L-lactic Acid (Sculptra Aesthetic) for the Treatment of Cellulite of the Buttocks and Thighs · NA · unknown

Other Galderma R&D trials

Trials by the same sponsor.

NCT07047690 — A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis · Phase 2 · recruiting
NCT07344584 — A Prospective Pilot Study to Evaluate Safety and Effectiveness of GP0122 and GP0124 for Correction of Lines and Wrinkles · NA · not yet recruiting
NCT07186413 — A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne · Phase 3 · recruiting
NCT07398989 — A Clinical Study to Assess Efficacy and Tolerability of a Topical Skincare Product on Adults With Mature, Crepey Skin · Phase 4 · completed
NCT06988618 — Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05463978 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Galderma R&D
Last refreshed: 24 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05463978.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing